GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Stockholders Equity

ME Therapeutics Holding (XCNQ:METX) Total Stockholders Equity : C$1.36 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Total Stockholders Equity?

ME Therapeutics Holding's Total Stockholders Equity for the quarter that ended in Feb. 2024 was C$1.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ME Therapeutics Holding's Book Value per Share for the quarter that ended in Feb. 2024 was C$0.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ME Therapeutics Holding's Debt-to-Equity for the quarter that ended in Feb. 2024 was 0.00.

ME Therapeutics Holding Total Stockholders Equity Historical Data

The historical data trend for ME Therapeutics Holding's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Total Stockholders Equity Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Total Stockholders Equity
-0.13 0.52

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Total Stockholders Equity Get a 7-Day Free Trial 0.57 0.52 0.52 0.39 1.36

ME Therapeutics Holding  (XCNQ:METX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ME Therapeutics Holding's Book Value per Share for the quarter that ended in Feb. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.364-0)/23.6345
=0.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ME Therapeutics Holding's Debt-to-Equity for the quarter that ended in Feb. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1.364
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines